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Genetic factors inﬂuence fetal alcohol spectrum disorders (FASDs) in both humans and
animals. Experiments using inbred and selectively bred mouse stocks that controlled for
(1) ethanol dose, (2) maternal and fetal blood ethanol levels, and (3) fetal developmental
exposure stage, show genotype can affect teratogenic outcome. Other experiments
distinguish the teratogenic effects mediated by maternal genotype from those mediated
by fetal genotype. One technique to distinguish maternal versus fetal genotype effect is
to utilize embryo transfers. This study is the ﬁrst to examine ethanol teratogenesis – fetal
weight deﬁcits and mortality, and digit, kidney, and vertebral malformations – in C57BL/6J
(B6) and DBA/2J (D2) fetuses that were transferred as blastocysts into B6 and D2 dams.We
hypothesized that, followingmaternal alcohol exposure, B6 andD2 fetuses gestatingwithin
B6 mothers, as compared to D2 mothers, will exhibit a higher frequency of malformations.
On day 9 of pregnancy, females were intubated (IG) with either 5.8 g/kg ethanol (E) or
maltose-dextrin (MD). Other females were mated within strain and treated with either
ethanol or maltose, or were not exposed to either treatment. Implantation rates were
affected by genotype. Results show more B6 embryos implanted into D2 females than B6
females (p < 0.05; 47% vs. 23%, respectively).There was no difference in the percentage
of D2 embryos implanting into B6 and D2 females (14 and 16%, respectfully). Litter
mortality averaged 24% across all experimental groups. Overall, in utero ethanol exposure
reduced mean litter weight compared to maltose treatment (E = 1.01 g; MD = 1.19 g;
p < 0.05); but maltose exposed litters with transferred embryos weighed more than
similarly treated natural litters (1.30 g vs. 1.11 g; p < 0.05). Approximately 50% of all
ethanol exposed B6 fetuses exhibited some malformation (digit, vertebral, and/or kidney)
regardless of whether they were transferred into a B6 or D2 female, or were naturally
conceived.This suggests the D2 maternal uterine environment did not offer any protection
against ethanol teratogenesis for B6 fetuses. One of the questions remaining is the how
the B6 uterine environment affects D2 teratogenesis. No deﬁnitive conclusions can be
drawn because too few viable D2 litters were produced.
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INTRODUCTION
Women who drink alcohol while pregnant risk having children
with congenital malformations (Jones and Smith, 1973, 1975). In
the most extreme cases Fetal Alcohol Syndrome (FAS) may be
diagnosed. The syndrome is hallmarked by pre- and postnatal
growth retardation, craniofacial abnormalities, and central ner-
vous system dysfunction including behavioral abnormalities. The
designation fetal alcohol spectrum disorder (FASD) is now used
as an umbrella term covering all outcomes associated with prena-
tal alcohol exposure. Not all children exposed to alcohol in utero
display FASD characteristics. This indicates individual differences
(both maternal and fetal) in ethanol teratogenesis susceptibility.
Many risk factors play a role in FASD development and several
studies point to genetic differences in susceptibility.
Mice are useful in studying FASD.All hallmark features of FASD
can be replicated inmice. Experiments using inbred and selectively
bred mouse stocks show genotype can affect teratogenic outcome
(Warren and Li, 2005). The deleterious outcomes under genetic
control include differing levels of embryo lethality; brain mor-
phology; fetal weight gain; and digit, skeletal, ocular, renal, and
heart anomalies; and behavioral anomalies (Gilliam et al., 1987,
1989; Goodlett et al., 1989; Gilliam and Kotch, 1990, 1992, 1996;
Boehm et al., 1997).
Some teratogenic effects are mediated by maternal genotype
and may be distinguished from those mediated by fetal geno-
type (Gilliam and Irtenkauf, 1990; Gilliam et al., 1997, 2011;
Downing and Gilliam, 1999). Reciprocal breeding between dis-
tinct mouse stocks identify these distinctions. A maternal effect
is indicated when genetically identical heterozygous offspring dif-
fer in responses based on which homozygous mouse stock is used
as the mother in the reciprocal cross (Biddle and Fraser, 1977).
If the difference is limited to male offspring or observed at a
higher rate in males, the maternal effect may be attributed to X-
linked genes. When the difference is not male-speciﬁc, maternal
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effects are presumably due to cytoplasmic inheritance, maternal
physiology, or epigenetic phenomena.
When C57BL/6J (B6) mice are crossed with any other mouse
stock, having a B6 mother signiﬁcantly increases malformation
frequency compared to not having a B6 mother (Gilliam and
Irtenkauf, 1990; Gilliam et al., 1997, 2011; Downing and Gilliam,
1999). In one study (Downing and Gilliam, 1999) we found a
maternal genetic effect on vertebral malformations in reciprocal
crosses of B6 and DBA/2J (D2) mice following alcohol expo-
sure. Furthermore, the source of the maternal effect could not
be ascribed to sex-linked genes or factors transmitted through
the egg cytoplasm. Two other factors may account for a mater-
nal effect. They are maternal uterine environment or epigenetic
phenomena. In the present study we used embryo transfers to
examine the independent effect of maternal uterine environ-
ment on ethanol teratogenesis. Genetically identical embryos can
be implanted into pseudo-pregnant recipient females with dif-
fering genotypes. If treatment effects on these offspring differ,
the difference can be attributed to maternal genotype. Con-
versely, embryos of differing genotype can be implanted into
genetically identical recipient females. If treatment effects on
these offspring differ, it can be attributed to fetal genotype.
Because we previously ruled out sex-linked genes and cytoplas-
mic factors accounting for the maternal effect in crosses of
B6 and D2 mice, we hypothesized that the B6 uterine envi-
ronment is responsible for increased vertebral malformation in
D2 fetuses. This is the ﬁrst study to examine how maternal
uterine environment affects ethanol teratogenesis using embryo
transfers.
MATERIALS AND METHODS
EXPERIMENTAL ANIMALS AND EMBRYO TRANSFER PROCEDURES
Experimental animals were B6 and D2 mice obtained from the
Jackson Laboratory (Bar Harbor, ME, USA) and maintained on
a normal light/dark cycle (lights on at 0700 h). All embryo
transfers were completed by James Gross, Mouse Genetics Core
Facility, National Jewish Health (NJH), 1400 Jackson St., Den-
ver, CO 80206, USA. Seven or eight 3.5-day blastocysts of the
same genotype were obtained from approximately 10-week old
donor females. These were implanted into each oviduct of pseudo-
pregnant recipient 10-week old recipient females (2.5 days post
coitus). By design, donor and recipient female ages were consis-
tent with those used in our previous studies (Boehm et al., 1997;
Downing and Gilliam, 1999). Subjects recovered from surgery at
NJH and were transported to the Animal Facility at the University
of Northern Colorado (UNCO) on day 7 of pregnancy.
EXPERIMENTAL TREATMENTS
Between 1230 and 1330 h on day 9 of pregnancy, females were
intragastrically intubated with either 5.8 g/kg ethanol (20% w/v)
or an isocaloric amount of a maltose-dextrin solution (35% w/v).
Naturally conceived (no embryo transplant) fetal groups were
established by mating females with same-strain males. These
females were treated with either ethanol or maltose-dextrin as
described above. Three B6 females mated to a B6 male were inad-
vertently not intubated. They remained in the experiment as an
unexposed control group.
TERATOLOGICAL ASSESSMENT
On day 18 of pregnancy females were killed by CO2 inhalation
and necropsied between 1400 and 1700 h. Uterine horns were
exposed and a countmade of live and resorbed fetuses. Live fetuses
were sexed, weighed, and prepared for either skeletal or soft tis-
sue examination, as previously described Gilliam et al. (2011). All
live fetuses were examined for digit malformations (ectrodactyly,
syndactyly). Approximately half of each litter was examined for
vertebral malformations (missing or fused vertebral arches and/or
centra), while the remaining half was examined for kidney mal-
formations (hydronephrosis, missing kidney). Examination of
uterine horn contents and fetal malformations was conducted by
the same person (DG), who was blind to prenatal treatment and
transferred embryo genotype.
PROTOCOL APPROVAL
Experimental procedures were approved by the Institutional Ani-
mal Care and Use Committees of the University of Northern
Colorado (Protocol 239-01) and National Jewish Health (Proto-
col AS2788-05-11). All procedures were conducted in accordance
with the Guide for the Care and Use of Laboratory Animals
[National Research Council (U.S.). Committee for the Update
of the Guide for the Care and Use of Laboratory Animals et al.,
2011].
STATISTICAL ANALYSES
Mean litter weight and percent litter mortality were examined by
ANOVAwith implant status (naturally conceived and transferred),
maternal genotype (B6 and D2), fetal genotype (B6 and D2),
and prenatal treatment (maltose, ethanol, and non-intubated)
as grouping factors. The proportion of successful implanta-
tions was calculated. The total number of embryos successfully
implantedwas dividedby the total number transferred. Successful-
implantation proportions for the same embryo genotype (either
B6 or D2) were compared between maternal genotypes (B6 vs.
D2) using the z-test for comparing two proportions, as described
by Bluman (2012). Since ethanol or maltose-dextrin treatments
were given 2–3 days after embryos normally achieve uterine
implantation, treatment effects on implantation success were not
examined. Comparisons of malformations were conducted using
the Fisher’s Exact Test Calculator for 2 × 2 Contingency Tables at:
http://research.microsoft.com/en-us/um/redmond/projects/msco
mpbio/ﬁsherexacttest/.
RESULTS
TRANSFER SUCCESS RATE
A total of 294 B6 blastocysts and 196 D2 blastocysts were trans-
ferred to B6 or D2 oviducts (Table 1). More B6 embryos
successfully implanted into D2 dams than into B6 dams (z-test
for comparing two proportions = −4.29, p < 0.05). In contrast,
there were no differences in the proportion of D2 embryos that
successfully implanted into D2 or B6 dams (z = 0.27; p > 0.05).
Teratogenic effects are often calculated on a per litter basis, there-
fore only litters with more than one implantation site are typically
included in tallying fetal mortality and/or malformations. Table 1
includes both the number of successful implants and proportions
of litters with more than one successful implant. Veriﬁcation
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Table 1 | Embryo transfer and implantation success rates.
B6 Damsa D2 Damsb
Total blastocysts
transferred
Successful
implants
Total
litters
Total litters
with > 1 implant
Total blastocysts
transferred
Successful
implants
Total
litters
Total litters
with > 1 implant
B6 Embryos 150 35 (23.3%) 10* 6 144 68 (47.2%) 9 7
D2 Embryos 126 18 (14.3%) 9 2 70 11 (15.7%) 5* 3
aThree B6 dams had zero B6 implants and seven had zero D2 implants.
bTwo D2 dams had zero B6 implants and one had zero D2 implants.
*One B6 litter had only one successful B6 embryo implantation and one D2 litter had only one successful D2 embryo implantation.
Table 2 | Mean percent litter mortality (±SEM).
B6Transferred D2Transferred B6 Natural D2 Natural
Maltose
(n = 3)
Ethanol
(n = 4)
Maltose Ethanol
(n = 2)
Unexposed
(n = 3)
Maltose
(n = 7)
Ethanol
(n = 8)
Maltose
(n = 2)
Ethanol
(n = 3)
B6 Dam 33.3
(16.7)
39.4
(16.3)
NA 44.4
(0)
11.1
(11.1)
20.2
(8.2)
10.1
(3.9)
22.7
(22.7)
14.3
(14.3)
Maltose
(n = 2)
Ethanol
(n = 5)
Maltose
(n = 2)
Ethanol
(n = 2)
D2 Dam 43.7
(6.2)
44.9
(14.5)
0 12.5
(12.5)
NA – data not available. Of the 9 B6 dams implanted with D2 embryos, three were treated with maltose, but none had any implants or live pups.
of zero implantations was made by compressing uterine horns
between two microscope slides.
LITTER MORTALITY
Litter mortality data were calculated by tabulating early and late
resorptions, as differentiated by Gleich and Frohberg (1977), and
dividing by total implantations. Average percent litter mortal-
ity for each treatment and genotype combination is shown in
Table 2. Mortality tended to be higher for litters with trans-
ferred embryos (34%) than for naturally conceived litters (15%).
However, analysis (ANOVA) of litter mortality indicated no
effects of pregnancy type (transferred vs. natural), maternal
genotype, fetal genotype, or treatment, nor were there any
interactions.
LITTER WEIGHT
A total of 43 litters had one or more live pups (see Table 3 for n’s).
Each pup was weighed on an electronic balance to 0.001 g. Treat-
ment effects on average litter weight for transferred embryos and
naturally conceived litters (within strainmating) for each genotype
combination are shown in Table 3.
Analysis of mean litterweight showed amain effect of treatment
[ethanol <maltose; F(2,42) = 4.58, p < 0.05] and an interaction
between pregnancy type (transferred vs. natural) and treatment
[ethanol vs. maltose; F(1,42) = 4.48, p < 0.05]. Litter weight
for both transferred and natural litters was similarly decreased by
FIGURE 1 | Fetal weight (grams) was similarly affected by ethanol
treatment in both transferred and naturally conceived fetuses
(p > 0.05), while maltose-exposed fetuses resulting from embryo
transfers weighed more than similarly treated naturally conceived
fetuses (p < 0.05).
ethanol exposure. In contrast, maltose exposed litters with trans-
ferred embryos weighedmore than similarly treated natural litters
(p < 0.05; Figure 1).
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Table 3 | Mean litter weight in grams (±SEM).
B6Transferred D2Transferred B6 Natural D2 Natural
Maltose
(n = 3)
Ethanol
(n = 4*)
Maltose Ethanol
(n = 2)
Unexposed
(n = 3)
Maltose
(n = 7)
Ethanol
(n = 8)
Maltose
(n = 2)
Ethanol
(n = 3)
B6 Dam 1.333
(0.098)
1.064
(0.085) NA
0.830
(0.078)
1.205
(0.027)
1.171
(0.039)
1.064
(0.037)
0.884
(0.021)
0.984
(0.090)
Maltose
(n = 2)
Ethanol
(n = 5*)
Maltose
(n = 2)
Ethanol
(n = 2)
D2 Dam 1.292
(0.001)
0.954
(0.052)
1.267
(0.060)
1.061
(0.270)
NA – data not available. Of the 9 B6 dams implanted with D2 embryos, three were treated with maltose, but none had any implants or live pups.
*Includes one litter with more than one implant but only one live pup.
Table 4 | Digit, kidney, and vertebral malformations.
B6Transferred D2Transferred B6 Natural D2 Natural
Maltose Ethanol Maltose Ethanol Unexposed Maltose Ethanol Maltose Ethanol
B6 Dam Digit 0/6 9/18 NA 0/10 0/25 0/42 20/69 0/11 0/16
Kidney 0/1 1/5 NA 1/4 0/13 2/24 9/38 1/5 2/9
Vertebral 0/5 2/13 NA 4/6 0/12 0/28 7/31 1/6 0/7
ANY 0/6 9/18 5/10 0/25 2/42 30/69 2/11 2/16
D2 Dam Digit 0/7 10/33 0/6 0/4
Kidney 0/3 5/15 0/3 1/1
Vertebral 0/4 5/18 0/3 0/3
ANY 0/7 16/33 0/6 1/4
Table numbers represent number of fetuses with a malformation (numerator) divided by total number of fetuses examined (denominator).
NA – data not available. Of the 9 B6 dams implanted with D2 embryos, three were treated with maltose, but none had any implants or live pups.
FETAL MALFORMATIONS
Malformations were tabulated for digits, vertebra, and kidneys
and are shown in Table 4. As expected, ethanol exposed B6 fetuses
exhibited more malformations than ethanol exposed D2 fetuses
(Fisher’s exact test, p = 0.06) regardless of implantation sta-
tus (naturally conceived or transferred). In fact, approximately
50% of all ethanol exposed B6 fetuses had some malforma-
tion. Importantly, malformation frequency for B6 fetuses did not
depend on whether they were naturally conceived or transferred
into D2 or B6 dams. This suggests the D2 uterine environ-
ment does not provide B6 fetuses protection from in utero
alcohol exposure, meaning no maternal genotype effect. In con-
trast to B6 fetuses, ethanol exposed D2 fetuses showed very
few malformations. The one exception was ethanol exposed D2
fetuses transferred to B6 dams; 50% had some malformation.
In particular, in utero ethanol increased vertebral malforma-
tions from 0% in D2 fetuses transferred to D2 dams to 67%
in D2 fetuses transferred to B6 dams. This suggests the B6
uterine environment may increase malformation frequency in
D2 fetuses, a maternal genotype effect. However, given the
low numbers of ethanol exposed D2 embryos, malformation
frequency was not signiﬁcantly different from other ethanol
exposed D2 groups.
DISCUSSION
These results suggest no protective effect of the D2 uterine envi-
ronment on ethanol teratogenesis. However there is some evidence
to suggest the B6 uterine environment can increase susceptibility.
But the lack of power due to genotype-dependent implantation
failure limits the reliability of this ﬁnding. Vertebral malforma-
tions were increased in D2 fetuses transferred to B6 dams, but
this result was not statistically signiﬁcant because of too few viable
D2 litters. In utero alcohol exposure produced similar malforma-
tion frequencies among B6 fetuses regardless of whether embryos
were transferred into a B6 or D2 dam or they resulted from nat-
ural mating. This suggests ethanol exposure occurred during the
same critical period of development among all B6 fetal groups.
That is, the transfer procedure did not change a key developmen-
tal stage sensitive to digit, vertebral, and kidney malformations.
Only ﬁfteen percent of D2 blastocysts successfully implanted and
only 35% of B6 blastocysts successfully implanted. A similar
difference was observed in the percentage of viable pups produced
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when D2 or B6 blastocysts were implanted into pseudo-pregnant
CByB6F1/J mice (Byers et al., 2006). Viable pup percentages were
25% for D2 implants but 53% for B6 implants. To assure mean-
ingful comparisons on sample sizes, future studies should at least
quadruple the number of litters with transferred D2 blastocysts
and double the number of litters with transferred B6 blastocysts.
Also, a focus on only skeletal (vertebral) malformations and not
soft-tissue (kidney) malformations would increase sample size.
A maternal effect for vertebral malformations and not kidney
malformations was previously observed (Downing and Gilliam,
1999).
Susceptibility to speciﬁc ethanol teratogenic effects in mice
appear to be due to both fetal and maternal genetic inﬂuences.
By making assumptions about additive and dominance genetic
effects, variation in total malformation frequency can be parti-
tioned into what is due to embryonic genotype and what is due
to maternal genotype. Interestingly, when maternal genetic inﬂu-
ences are observed they account for more than half of the total
malformation frequency (Gilliam and Irtenkauf, 1990; Gilliam
et al., 1997, 2011; Downing and Gilliam, 1999). Recently, using
stocks related to B6 and D2 mice, Lossie et al. (2014) identiﬁed
speciﬁc genes showing up-regulation in B6 embryos but down-
regulation in D2 embryos after ethanol exposure. These ﬁndings
are consistent with others when using embryo cultures (Ogawa
et al., 2005; Chen et al., 2011). Determining how these genes
are differentially regulated by maternal factors would shed light
on the maternal contribution to ethanol teratogenesis. Uncov-
ering the reasons for a maternal effect in mice may lead to
a better understanding of why only certain babies have FAS
or FASD.
Because of the increased vertebral malformations observed
in ethanol exposed D2 embryos transferred to B6 dams, it is
tempting to speculate that the B6 uterine environment somehow
changed fetal D2 gene expression. In support of this hypoth-
esis, Downing et al. (2012) measured gene expression changes
following in utero alcohol exposure in four embryonic geno-
types: true-bred B6 and D2, and reciprocally bred B6D2 and
D2B6. The mating period, time of intubation, and ethanol
and maltose dosages were all nearly identical to those used
in the present study. Of speciﬁc interest was the ﬁnding that
22 genes were differentially expressed in B6D2 embryos ges-
tating within B6 dams but not in genetically identical D2B6
embryos gestating within D2 dams following in utero alco-
hol exposure. B6D2 fetuses also show signiﬁcantly higher rates
of ethanol teratogenesis than do D2B6 fetuses (Downing and
Gilliam, 1999). These results implicate the B6 uterine environ-
ment as increasing FASD risk. These effects could also be due
to changes in fetal and/or placental genomic imprinting status
(Nelissen et al., 2011). The interplay between maternal genetic
factors and fetal genetic factors that increase FASD susceptibil-
ity need further study to unravel the underlying mechanisms
responsible.
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